WASHINGTON – Today, the Association for Accessible Medicines (AAM) announced the Black Women’s Health Imperative (BWHI) as the winner of its 2021 Champions of Access award. AAM CEO Dan Leonard presented the award at Access! 2021, the association’s annual meeting. Founded in 1983, the Black Women’s Health Imperative is the only national organization dedicated solely to improving the health
Americans consistently say congressional action is needed to lower the price of the medicines we need to stay healthy and live productively. In a January 2021 Politico/Harvard T.H. Chan School of Public Health survey, drug prices came second only to COVID-19 relief as the issue we care most about, with 95% of Democrats and 82%
Dan Leonard, longtime leader of the National Pharmaceutical Council who became CEO of the Association for Accessible Medicines in September, discusses the impact of generic medications on health care, and the challenges and opportunities facing the industry. Among the issues addressed are generics’ role in treating COVID-19 patients, the emergence of biosimilars, and the
WASHINGTON — The Association for Accessible Medicines’ president and CEO Dan Leonard issued the following statement on the 2020 election: “The Association for Accessible Medicines looks forward to working with the incoming Biden-Harris administration to achieve our shared goal of increasing access to safe, effective and affordable generic and biosimilar prescription medicines for all Americans.
WASHINGTON — The Association for Accessible Medicines (AAM) has released the 2020 Access & Savings Report detailing the economic benefit of generic and biosimilar drugs to America’s patients. According to the report, the U.S. health care system saved $313 billion in 2019 from generics and biosimilar drugs, including $96 billion in Medicare savings and $48.5 billion in
WASHINGTON — Dan Leonard on Tuesday was named president and chief executive officer of the Association for Accessible Medicines. He will join AAM in September. He most recently served as president and CEO of the National Pharmaceutical Council (NPC), and succeeds Chester “Chip” Davis, Jr. who left AAM in February to head the Healthcare Distribution
As I write this column, I’m working at home, social distancing from others not in my immediate family, yet keeping close to my coworkers and community through a blend of online video and other communications. As COVID-19 continues to spread across the United States, I wonder when we will return to “normal” — or even
Our nation’s ongoing health care debates have been rancorous, a situation that’s not likely to improve in 2020 with a presidential election. Rather than make predictions in this column, this year I’m outlining a wish list for the health care sector, actions we can all take to make health care more efficient, reduce wasteful spending,
WASHINGTON — The National Pharmaceutical Council (NPC) announced that Blasine Penkowski, chief strategic customer officer of Johnson & Johnson Health Care Systems Inc., has been elected chair of NPC’s board of directors for 2019-2020. Penkowski has served in other NPC board positions, most recently as vice chair. “Companies driving biopharmaceutical innovation face diverse challenges in
During the last few months, we’ve seen an intense focus on the cost of medicines, including a Senate hearing featuring seven biopharmaceutical executives. But the conversations about medicines, like the Senate hearing, have been narrowly focused on list and net prices or on specific medicines, rather than taking a holistic view of health spending or
There has been significant focus and attention paid to the issue of drug prices in the last few years. As Adam Fein, president of Pembroke Consulting Inc. and chief executive officer of Drug Channels Institute, has said, “Drugs are 12% of the costs, but 90% of the conversation.” Fortunately, the spirited national conversation about drug
WASHINGTON — The National Pharmaceutical Council (NPC) today announced that Richard Bagger, executive vice president, corporate affairs and market access, Celgene Corp., has been elected chair of NPC’s board of directors for 2018-2019. Bagger has previously served in several leadership roles at NPC, including as vice chair and treasurer. “Rich’s deep experience in health care, particularly
NEW YORK — Health care economists, health system leaders and policy makers have been talking seriously about measuring and paying for value in health care for more than a decade. Hospitals, clinics, pharmacies and practitioners across the country now are starting to move in that direction, incentivized since 2015 by Medicare’s adoption of alternative care
Today we’re seeing significant scientific breakthroughs that are revolutionizing the treatment of challenging conditions like cancers and both rare and chronic diseases. Advances that activate the immune system or retool genes with a single treatment to change the course of disease all signal that personalized medicine is here and continuing to evolve. These amazing and
